Review: taking Zantac 150 and Savella together


Summary

Drug interactions are reported among people who take Zantac 150 and Savella together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Savella. It is created by eHealthMe based on reports of 50 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Zantac 150 and Savella >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 150 3,880 users)

Savella

Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. (latest outcomes from Savella 3,324 users)

On Jul, 28, 2016

50 people who take Zantac 150, Savella are studied.


Number of reports submitted per year:

Zantac 150 and Savella drug interactions.

Drug effectiveness over time:

Zantac 150:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)
Savella:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 20.0% - (1 of 5 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zantac 150:
  • female: 63.0% - (7 of 11 people)
  • male: 50.0% - (1 of 2 people)
Savella:
  • female: 30.0% - (3 of 10 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Zantac 150:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 100.0% - (4 of 4 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 40.0% - (2 of 5 people)
  • 60+: 0.0% - (0 of 0 people)
Savella:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • nausea
  • blepharospasm
  • depression
  • fatigue
  • headache
  • hyperhidrosis
  • abdominal pain
  • constipation
  • convulsion
  • crying
1 - 6 months:
  • hyperhidrosis
  • increased appetite
6 - 12 months:
  • wheezing aggravated
  • fever
  • hot flushes
1 - 2 years:
  • blepharospasm
  • fever
  • hot flushes
  • wheezing aggravated
2 - 5 years:
  • hair loss
  • depression
  • diarrhoea
5 - 10 years:
  • diarrhoea
not specified:
  • drug ineffective
  • nausea
  • pain
  • depression
  • diarrhoea
  • fibromyalgia
  • gastrooesophageal reflux disease
  • hypertension
  • pneumonia
  • psoriatic arthropathy

Most common drug interactions by gender *:

female:
  • nausea
  • depression
  • blepharospasm
  • diarrhoea
  • drug ineffective
  • hyperhidrosis
  • pneumonia
  • abdominal pain
  • dry mouth
  • fatigue
male:
  • arteriosclerosis coronary artery
  • arthritis
  • blood osmolarity decreased
  • blood sodium decreased
  • bronchospasm
  • depression
  • fibromyalgia
  • gastrooesophageal reflux disease
  • hypercholesterolaemia
  • hypertension

Most common drug interactions by age *:

30-39:
  • drug screen positive
  • hepatic enzyme increased
  • cystitis interstitial
  • dehydration
  • diarrhoea
40-49:
  • blepharospasm
  • pneumonia
  • convulsion
  • crying
  • depressed mood
  • depression
  • dry mouth
  • fatigue
  • headache
  • hyperhidrosis
50-59:
  • depression
  • abdominal pain
  • arteriosclerosis coronary artery
  • arthritis
  • bronchospasm
  • fibromyalgia
  • gastrooesophageal reflux disease
  • hypercholesterolaemia
  • hypertension
  • metabolic syndrome
60+:
  • blood osmolarity decreased
  • blood sodium decreased
  • hiatus hernia
  • inappropriate antidiuretic hormone secretion
  • eye pain
  • hyperhidrosis
  • increased appetite
  • abdominal mass
  • affect lability
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Savella?

Can you answer these questions?

More questions for: Zantac 150, Savella

You may be interested in these reviews

More reviews for: Zantac 150, Savella

On eHealthMe, Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Savella (milnacipran hydrochloride) is often used to treat fibromyalgia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.